GlassScriptPhysician profile
Katelyn Mellion
NPI 1356752828
$3,966.62
in general payments reported to CMS, 2019-2025
9 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,067 · 2021: $316 · 2022: $249 · 2023: $439 · 2024: $743 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,321 · Travel and Lodging: $13.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,320.99 |
| Travel and Lodging | $13.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,469.62 | 2019-2024 | |
| Medtronic, INC. | $759.92 | 2021-2025 | Signia |
| W. L. Gore & Associates, INC. | $188.06 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Karl Storz Endoscopy-America | $166.74 | 2021 | |
| Ambu INC. | $142.39 | 2024 | |
| Merit Medical Systems INC | $121.10 | 2025 | Esophyx |
| Boston Scientific Corporation | $92.92 | 2024 | Apollo Esg System |
| Acell, INC. | $13.12 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Mellion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.